Find similar products:
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 55295/0004.
Qinlock 50mg Tablets
QINLOCK 50 mg tablets
ripretinib
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What QINLOCK is and what it is used for
2. What you need to know before you take QINLOCK
3. How to take QINLOCK
4. Possible side effects
5. How to store QINLOCK
6. Contents of the pack and other information
QINLOCK is a cancer medicine containing the active substance ripretinib, a protein kinase inhibitor. Protein kinase inhibitors are used to treat cancer by stopping the activity of certain proteins that are involved in the growth and spread of cancer cells.
QINLOCK is used to treat adults with gastrointestinal stromal tumour (GIST), a rare type of cancer of the digestive system including the stomach and bowel, that has:
If you have any questions about how QINLOCK works or why this medicine has been prescribed for you, please ask your doctor.
Do not take QINLOCK if you are allergic to ripretinib or any of the other ingredients of this medicine (listed in section 6).
Before taking QINLOCK, talk to your doctor or pharmacist if you have or have a history of:
When taking QINLOCK, talk to your doctor or pharmacist if:
Important information for men and women about contraception
QINLOCK can cause harm to your unborn baby. Do not become pregnant while taking QINLOCK. Use effective contraception during treatment and for at least 1 week after the final dose of QINLOCK if you are a female of childbearing potential or a male with a female partner of childbearing potential. If using hormonal contraception, add a barrier contraception (such as condoms). See section on ‘Contraception, pregnancy, breastfeeding and fertility’.
Do not give this medicine to children and adolescents below 18 years of age because it has not been studied in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
QINLOCK can affect the way some medicines work. Also, some medicines can affect the way QINLOCK works.
In particular, tell your doctor if you are taking any of the following medicines:
Grapefruit juice may change the amount of QINLOCK in your body. Drinking grapefruit juice or eating grapefruit is not recommended during treatment with this medicine.
Contraception
Both women of childbearing potential and men should use effective contraception during treatment and for at least 1 week after completion of treatment. If hormonal contraception is used, a barrier method (such as condoms) should be added.
Pregnancy
If you are pregnant, think you may be pregnant or are planning to have a baby, you should not take this medicine, unless your doctor has decided that treatment with QINLOCK is clearly necessary. Ask your doctor or pharmacist for advice before taking this medicine.
Do not get pregnant while you are being treated with QINLOCK.
If you are a male patient with a partner who is either pregnant or who could become pregnant, you must use a barrier method (such as condoms) during sexual intercourse, during treatment and for at least 1 week after completion of treatment. This medicine may harm your unborn baby.
If you are a male and your female partner becomes pregnant during your treatment with QINLOCK, tell your doctor right away.
Woman of childbearing potential will have to do pregnancy tests before treatment start with QINLOCK and during treatment.
Breastfeeding
Do not breast-feed your baby during treatment with QINLOCK and for at least 1 week after completing treatment, as this medicine may cause serious side effects in your baby. Tell your doctor if you are breast-feeding or planning to breast-feed.
Fertility
QINLOCK may affect fertility in men and women. Ask your doctor for advice before taking QINLOCK.
QINLOCK does not directly affect your ability to drive or use machines. If you feel unwell or very tired while being treated with QINLOCK you should not drive or operate machinery until you feel safe to do so.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
QINLOCK will be prescribed for you by a doctor experienced in using anticancer therapies.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended daily dose is three 50 mg tablets (150 mg) once daily.
Take the tablets at the same time each day with or without food. Swallow the tablets whole with a glass of water and do not chew, split, or crush the tablets. Do not take any tablets that are broken, cracked, or otherwise damaged due to unknown effects of taking tablet that are not whole.
If you have to take certain other medicines at the same time as QINLOCK, your doctor may change your dose to three 50 mg tablets (150 mg) twice daily.
You will usually take QINLOCK as long as you are benefitting from it and not suffering unacceptable side effects (see section 4); however, your doctor may reduce your dose, or may decide to interrupt or stop the treatment temporarily or permanently if necessary.
If you have liver or kidney problems
While you are being treated with QINLOCK, your doctor will monitor your liver or kidney function more closely.
If you have accidentally taken too many tablets, seek urgent medical attention.
What to do if you forget to take this medicine, depends on when you remember the dose that has been forgotten. If it is:
Do not take a double dose to make up a forgotten dose.
If you are sick (vomiting) after taking this medicine, do not take an additional dose, but carry on as normal. Take your next dose of tablets the next day at the usual time and tell your doctor you have been sick.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Seek urgent medical attention if you experience any of the following serious side effects (see section 2):
Talk to your doctor or pharmacist if you experience:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the bottle label after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special temperature storage conditions.
Store in the original package and keep the bottle tightly closed in order to protect from light and moisture.
Do not use this medicine if you notice that the pack is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
QINLOCK tablets are white to off-white, oval in shape, and debossed with ‘DC1' on one side.
Each bottle is child-resistant and contains 30 or 90 tablets and a desiccant.
The bottles are provided with aluminium foil/polyethylene (PE) tamper evident seal. The desiccant is a moisture absorbing material filled in a small container to protect the tablets from moisture. Always keep the desiccant pouch in the bottle and do not eat it.
Not all pack sizes may be marketed.
This leaflet was last revised in MAR 2022